Topiramate Capsule
Product Images NDC 24979-210

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 24979-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure1 (Figure 1)

Figure1 (Figure 1)
This text appears to be a chart displaying cumulative rates for time to the first seizure. The chart shows rates at different time intervals, ranging from 0 to 500 days. The rates are represented by percentage values, ranging from 0.00% to 5.0%, which are likely associated with different dosages of a medication called Topamax. The dosages mentioned include 50 mg/day (N=234) and 400 mg/day (N=236). A significant p-value of 0.0002 suggests a statistically significant difference between the two dosages in terms of their effectiveness in preventing seizures.*
FDA Label Image

Figure2 (Figure 2)

Figure2 (Figure 2)
FDA Label Image

Label 15mg (Label 15)

Label 15mg (Label 15)
This text appears to be a description of a medication called Topiramate. Each capsule contains 15 mg of the active ingredient, and it should be stored in a tight container at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions to 15°C to 30°C (59°F to 86°F). The capsules are white to off-white, spherical-shaped coated pellets and are marked with "15 mg" on the body and "TWi T210" on the cap. The medication is manufactured by TWi Pharmaceuticals USA, Inc. in Paramus, NJ. The NDC number for the medication is 24979-210-04, and it is available in a package containing 60 capsules. The pharmacist should dispense the accompanying Medication Guide to each patient.*
FDA Label Image

Label 25mg (Label 25)

Label 25mg (Label 25)
Each capsule of this product contains 25 mg of topiramate, which is used for various medical conditions. It is important to follow the dosage and prescribing information provided in the product literature. The capsules should be kept in a tight container and stored at a temperature between 20° and 25°C (68° to 77°F), with limited excursions allowed. Protection from moisture is recommended, and the product should be kept out of reach of children. The capsules themselves are white to off-white in color, with a spherical shape and a coating. The capsule body is white and opaque, with the marking "25 mg", while the cap is clear and marked as "TWi T211". The product is manufactured by TWi Pharmaceuticals in Taoyuan City, Taiwan, and is distributed by TWi Pharmaceuticals USA, Inc. based in Paramus, NJ. The product is available in a package containing 60 capsules. Pharmacists are directed to dispense the medication guide along with the product to each patient. Unfortunately, the remaining text from the output is not readable and cannot be used to generate a useful description.*
FDA Label Image

Logo (Logo 2)

Logo (Logo 2)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.